Free Trial

Procter & Gamble (NYSE:PG) Reaches New 1-Year High at $167.65

Shares of The Procter & Gamble Company (NYSE:PG - Get Free Report) hit a new 52-week high on Monday . The stock traded as high as $167.65 and last traded at $166.78, with a volume of 706531 shares. The stock had previously closed at $166.85.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Wells Fargo & Company upped their target price on Procter & Gamble from $162.00 to $170.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 24th. Jefferies Financial Group upped their price target on Procter & Gamble from $175.00 to $182.00 and gave the stock a "buy" rating in a research note on Monday, April 22nd. Barclays raised their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 23rd. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Procter & Gamble from $172.00 to $171.00 and set a "buy" rating for the company in a research report on Monday, April 22nd. Finally, JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $169.00 to $162.00 and set an "overweight" rating on the stock in a research note on Thursday, January 18th. Seven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $169.76.

Get Our Latest Report on PG


Procter & Gamble Stock Down 0.6 %

The firm has a market capitalization of $391.48 billion, a price-to-earnings ratio of 27.08, a P/E/G ratio of 3.39 and a beta of 0.43. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The firm has a fifty day moving average price of $160.63 and a 200 day moving average price of $154.84.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The business had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same period in the previous year, the business earned $1.37 EPS. Procter & Gamble's revenue was up .6% compared to the same quarter last year. Sell-side analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a $1.0065 dividend. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. This is a boost from Procter & Gamble's previous quarterly dividend of $0.94. Procter & Gamble's dividend payout ratio is currently 65.69%.

Insider Activity at Procter & Gamble

In related news, COO Shailesh Jejurikar sold 31,859 shares of the business's stock in a transaction on Monday, May 6th. The shares were sold at an average price of $164.90, for a total value of $5,253,549.10. Following the transaction, the chief operating officer now owns 9,739 shares in the company, valued at $1,605,961.10. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,859 shares of the business's stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $164.90, for a total value of $5,253,549.10. Following the transaction, the chief operating officer now directly owns 9,739 shares in the company, valued at $1,605,961.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 21,388 shares of the business's stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $164.98, for a total transaction of $3,528,592.24. Following the completion of the transaction, the chief executive officer now owns 36,854 shares in the company, valued at $6,080,172.92. The disclosure for this sale can be found here. Insiders sold a total of 140,112 shares of company stock worth $22,841,321 in the last quarter. Corporate insiders own 0.17% of the company's stock.

Institutional Trading of Procter & Gamble

A number of institutional investors have recently modified their holdings of PG. Advantage Trust Co purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $28,000. Naples Money Management LLC purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $29,000. Ruedi Wealth Management Inc. lifted its stake in Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company's stock worth $32,000 after purchasing an additional 77 shares in the last quarter. Wyrmwood Management LLC purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $29,000. Finally, Transcendent Capital Group LLC bought a new position in shares of Procter & Gamble in the 4th quarter worth $31,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Featured Articles and Offers

Search Headlines: